• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall PAPR (Powered AirPurifying Respirator)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall PAPR (Powered AirPurifying Respirator)see related information
Date Initiated by FirmJuly 02, 2020
Create DateAugust 14, 2020
Recall Status1 Terminated 3 on June 25, 2021
Recall NumberZ-2815-2020
Recall Event ID 86034
Product Classification Respirator, n95, for use by the general public in public health medical emergencies - Product Code NZJ
ProductPAPR (Powered Air-Purifying Respirator) - Model# WLPAPR20W1
Code Information Lot code: JX20 (or week #20 of 2020)
FEI Number 1826917
Recalling Firm/
Manufacturer
Whirlpool Corporation
World Headquarters
Benton Harbor MI 49022
For Additional Information ContactChristian Gianni
616-926-5203
Manufacturer Reason
for Recall
The rivets that secure the elastic headband to the face shield have the potential to be mis-assembled. When this condition occurs, it can result in a headband that can become loose from face shield allowing the face shield to shield on the user.
FDA Determined
Cause 2
Manufacturing material removal
ActionCustomers were contacted via email/telephone beginning 6/18/20. Rework was conducted in-house at the customer facilities.
Quantity in Commerce528 units
DistributionThe products were distributed to the following US states: MI.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
-
-